Status:
COMPLETED
Evaluation of Diagnostic Performance of Cerebral Perfusion Scans in Pseudo-Stroke
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Conditions:
Stroke, Acute
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
When a patient is received with the context of acute stroke, they undergo a fast neurological evaluation and obtain a basic appraisal composed of a non-contrast endovascular cerebral scan and an angio...
Detailed Description
With this study, the investigators wish to evaluate the diagnostic value of two additional radiological examinations: 1. Computed tomography perfusion (CTP) imaging to evaluate blood flow in the brai...
Eligibility Criteria
Inclusion
- Admission at CHUM for acute neurological deficit \<4,5h (since the onset of symptoms)
- Potential candidate for an intravenous thrombolysis
- Cerebral angioscan performed at CHUM at the time of admission
- Age ≥ 18 years
- Observed period from September 2019 à June 2020
Exclusion
- Contraindication to intravenous thrombolysis according to the doctor in charge of treatment;
- Indication of a thrombectomy;
- Incomplete exam or exam of insufficient technical quality for a reliable radiological interpretation;
- Contraindication against MRI .
Key Trial Info
Start Date :
October 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 4 2022
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT04105257
Start Date
October 20 2019
End Date
October 4 2022
Last Update
December 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre hospitalier de l'Université de Montréal (CHUM)
Montreal, QC - Québec, Canada, H2X0C1